p62/SQSTM1 Participates in the Innate Immune Response of Macrophages Against Candida albicans Infection

被引:0
|
作者
He YanZhi [1 ,2 ,3 ,4 ,5 ,6 ]
Duan ZhiMin [7 ,8 ,9 ,4 ,10 ,6 ]
Chen Xu [1 ,2 ,3 ,4 ,5 ,6 ]
Li Min [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Center for Global Health
[2] School of Public Health
[3] Nanjing Medical University
[4] Nanjing
[5] Jiangsu
[6] China
[7] Department of Dermatology
[8] Hospital for Skin Diseases (Institute of Dermatology)
[9] Chinese Academy of Medical Sciences and Peking Union Medical College
[10] Jiangsu
关键词
p62/SQSTM1; Candida albicans; macrophage; innate immune response; phagocytosis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objective: This study was designed to evaluate whether p62/SQSTM1 (hereafter referred to as p62) is involved in the immune response of macrophages against challenge byCandida albicans (C. albicans).Methods: We cultured bone marrow-derived macrophages (BMDMs) to investigate the immune response to challenge byC. albicans. The p62 gene was knocked down by transfection with p62 small interfering RNA (siRNA) in the p62 siRNA group. BMDMs transfected with nonsense siRNA served as the negative control (NC) group. These two groups of BMDMs were challenged withC. albicans in vitro. We detected p62 expression through quantitative reverse transcription PCR and western blotting. The phagocytosis ability of BMDMs was evaluated by flow cytometry and microscopic examination using an Olympus FV1000 laser scanning confocal microscope. Moreover, we determined the level of reactive oxygen species (ROS) in BMDMs. The mRNA levels of proinflammatory cytokines were determined by quantitative reverse transcription PCR.Results: After stimulation byC. albicans, the relative expression of p62 mRNA was increased in a dose-dependent manner, the relative expression of p62 and the ratio of BMDMs toC. albicans is 1.893 ± 0.2156 (1:1,P < 0.05), 2.873 ± 0.4787 (1:3,P < 0.05) and 3.556 ± 0.2892 (1:5,P < 0.01). The p62 protein level was also increased. After transfection with p62 siRNA, the mRNA and protein levels of p62 were significantly decreased in BMDMs (P < 0.05). After 0.5, 1 and 2 hours of co-culture of BMDMs withC. albicans, flow cytometry showed that the phagocytosis rates ofC. albicans by BMDMs were significantly lower in the p62 siRNA group than in the NC group (39.70 ± 1.69%vs. 55.23 ± 0.72%, 46.70 ± 0.89%vs. 60.80 ± 1.78%, 51.90 ± 0.98%vs. 64.43 ± 2.0%, respectively, allP < 0.05). Consistent results were seen in the production of ROS (4269 ± 392.6vs. 13426 ± 1859.7, 4967 ± 721.2vs. 13687 ± 2611.2, 7647 ± 1950.0vs. 17719 ± 1814.2, respectively, allP < 0.05). The ROS levels were higher in BMDMs of the NC group than in BMDMs transfected with p62 siRNA at 0.5, 1, and 2 hours after treatment withC. albicans. BMDMs was co-cultured withC. albicans for 4 and 12 hours, the mRNA levels of interleukin-1β and interleukin-18 in NCs were also higher than p62 siRNA group, interleukin-1β: (6.14 ± 1.63vs. 12.12 ± 0.54, 8.81 ± 0.86vs. 26.2 ± 4.67, respectively, allP < 0.05), IL-18: (0.38 ± 0.02vs. 0.97 ± 0.06, 0.44 ± 0.02vs. 2.23 ± 0.46, respectively, allP < 0.05).Conclusion: p62 plays an important role in the process of phagocytosis in BMDMs challenged byC. albicans through ROS production and expression of proinflammatory cytokines.
引用
收藏
相关论文
共 50 条
  • [41] p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
    Tan, Chong Teik
    Soh, Natalie Jun Hui
    Chang, Hao-Chun
    Yu, Victor C.
    FEBS JOURNAL, 2023, 290 (04) : 892 - 912
  • [42] AMPA Receptor Trafficking and Synaptic Plasticity Require SQSTM1/p62
    Jiang, Jianxiong
    Parameshwaran, Kodeeswaran
    Seibenhener, M. Lamar
    Kang, Myoung-Goo
    Suppiramaniam, Vishnu
    Huganir, Richard L.
    Diaz-Meco, Maria T.
    Wooten, Marie W.
    HIPPOCAMPUS, 2009, 19 (04) : 392 - 406
  • [43] An unexpected tumor suppressor role of SQSTM1/p62 in liver tumorigenesis
    Chao, Xiaojuan
    Ni, Hong-Min
    Ding, Wen-Xing
    AUTOPHAGY, 2022, 18 (02) : 459 - 461
  • [44] Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62
    J-P Pursiheimo
    K Rantanen
    P T Heikkinen
    T Johansen
    P M Jaakkola
    Oncogene, 2009, 28 : 334 - 344
  • [45] p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria
    Okatsu, Kei
    Saisho, Keiko
    Shimanuki, Midori
    Nakada, Kazuto
    Shitara, Hiroshi
    Sou, Yu-shin
    Kimura, Mayumi
    Sato, Shigeto
    Hattori, Nobutaka
    Komatsu, Masaaki
    Tanaka, Keiji
    Matsuda, Noriyuki
    GENES TO CELLS, 2010, 15 (08) : 887 - 900
  • [46] p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis
    Li, Si-Si
    Xu, Ling-Zhi
    Zhou, Wei
    Yao, Shang
    Wang, Chun-Li
    Xia, Jiang-Long
    Wang, He-Fei
    Kamran, Muhammad
    Xue, Xiao-Yuan
    Dong, Lin
    Wang, Jing
    Ding, Xu-Dong
    Bella, Laura
    Bugeon, Laurence
    Xu, Jie
    Zheng, Fei-Meng
    Dallman, Margaret J.
    Lam, Eric W. -F.
    Liu, Quentin
    CARCINOGENESIS, 2017, 38 (11) : 1092 - 1103
  • [47] mTOR Mediates p62/SQSTM1 Synthesis in Pancreatic Acinar Cells
    Pimienta, M.
    Lee, G. E.
    Gukovskaya, A. S.
    Gukovsky, I.
    Mareninova, O. A.
    PANCREAS, 2014, 43 (08) : 1401 - 1401
  • [48] Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62
    Pursiheimo, J-P
    Rantanen, K.
    Heikkinen, P. T.
    Johansen, T.
    Jaakkola, P. M.
    ONCOGENE, 2009, 28 (03) : 334 - 344
  • [49] Structure and function of p62/SQSTM1 in the emerging framework of phase separation
    Berkamp, Sabrina
    Mostafavi, Siavash
    Sachse, Carsten
    FEBS JOURNAL, 2021, 288 (24) : 6927 - 6941
  • [50] Tumor SQSTM1 (p62) expression and T cells in colorectal cancer
    Kosumi, Keisuke
    Masugi, Yohei
    Yang, Juhong
    Qian, Zhi Rong
    Kim, Sun A.
    Li, Wanwan
    Shi, Yan
    da Silva, Annacarolina
    Hamada, Tsuyoshi
    Liu, Li
    Gu, Mancang
    Twombly, Tyler S.
    Cao, Yin
    Barbie, David A.
    Nosho, Katsuhiko
    Baba, Hideo
    Garrett, Wendy S.
    Meyerhardt, Jeffery A.
    Giovannucci, Edward L.
    Chan, Andrew T.
    Fuchs, Charles S.
    Ogino, Shuji
    Nishihara, Reiko
    ONCOIMMUNOLOGY, 2017, 6 (03):